Brivaracetam gets PBS listing recommendation for children

The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended that the PBS subsidy criteria for the anti-epilepsy drug brivaracetam (Briviact) be extended to children. At its November 2019 meeting the Committee made a positive recommendation  to change the Authority Required (STREAMLINED) listings for brivaracetam for the treatment of intractable partial onset epileptic seizures, to include patients ...

Already a member?

Login to keep reading.

© 2021 the limbic